Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.

M Wetzler, M Talpaz, RA Van Etten… - The Journal of …, 1993 - Am Soc Clin Investig
Cell lines. We used the CML blastic crisis cell line K562 (Ph '-positive), the promyelocytic
leukemia cell line HL-60 (Ph'-negative), the acute myelogenous leukemia cell line KG-I (Ph'-…

In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

P Le Coutre, L Mologni, L Cleris… - Journal of the …, 1999 - academic.oup.com
Bcr/Abl tyrosine kinase. METHODS: Nude mice were given an injection of the Bcr/Abl-positive
human leukemia cell … (2-5 hours) inhibition of Bcr/Abl kinase activity. On the basis of the …

Molecular pathways: Bcr-abl

D Cilloni, G Saglio - Clinical Cancer Research, 2012 - AACR
… myeloid leukemia (CML) … BCR-ABL oncogene that encodes for the chimeric BCR-ABL
oncoprotein, with constitutive kinase activity that promotes the growth advantage of leukemic cells (…

BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia

S Salesse, CM Verfaillie - Oncogene, 2002 - nature.com
… therefore be needed to induce cell death in most leukemic cells, which may interfere with …
is evidence that BCR/ABL mRNA and protein may not be expressed in CML stem cells. Ex …

BCR-ABL in chronic myelogenous leukemia–how does it work?

JM Goldman, JV Melo - Acta haematologica, 2008 - karger.com
… in DSBs in leukemia cells [45] . In addition, BCRABL-positive leukemia cells accumulate more
… Unfortunately, Bcr-Abl kinase may also reduce the fidelity of DSB repair mechanisms such …

Expression of bcr And bcr-abl Fusion Transcripts in Normal and Leukemic Cells

S Collins, H Coleman, M Groudine - Molecular and cellular biology, 1987 - Taylor & Francis
… -positive chronicmyelogenous leukemia (CML) generates an aberrant bcr-abl fusion … bcr-abl
transcript, we studied the patterns of expression of the normal ber gene in different cell types…

BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15; 83 (12): 3835]

A McGahon, R Bissonnette, M Schmitt, KM Cotter… - 1994 - ashpublications.org
… of chemotherapeutic agents on tumor cells, and therefore the … leukemia (CML) cell line
expressing the BCR-ABL fusion … tion start of bcr downregulate bcr-ab/ protein in these cells and …

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCRABL tyrosine kinase

P Vigneri, JYJ Wang - Nature medicine, 2001 - nature.com
… Our results indicate an interesting approach to treating CML, by trapping BCRABL in the
nucleus of leukemic cells and thus converting BCRABL into a terminator of this disease. …

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis

C Gambacorti-Passerini, P Le Coutre, L Mologni… - Blood Cells, Molecules …, 1997 - Elsevier
… against v-abl transformed murine neoplastic cells (11); in … cellular effects of CGP57148B in
BCR/ ABL leukemic cells (including 14 fresh patient samples), and in BCR/ABL negative cells, …

ABL-BCR expression in BCR-ABL-positive human leukemia cell lines

CC Uphoff, S Habig, S Fombonne, Y Matsuo… - Leukemia research, 1999 - Elsevier
… of BCR and ABL in t(9;22) positive leukemia cell lines, which include the normal BCR and
ABL1b … gene of the Ph chromosome (BCR-ABL) and the mRNAs of the reciprocal fusion gene (…